Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV002308412 | SCV002603345 | likely pathogenic | Congenital amegakaryocytic thrombocytopenia | 2022-01-02 | criteria provided, single submitter | clinical testing | NM_005373.2(MPL):c.155G>A(W52*) is expected to be pathogenic in the context of congenital amegakaryocytic thrombocytopenia. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in MPL, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. |